ask="5.61"
ask_size="2000"
average_daily_volume="1441000"
bid="4.00"
bid_size="200"
book_value="0.21"
change="+0.03"
change_from_200_day_moving_average="-0.43"
change_from_50_day_moving_average="-0.40"
change_from_52_week_high="-2.98"
change_From_52_week_low="0.83"
change_in_percent="+0.63%"
close="4.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-0.67"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="71286000"
high="4.95"
high_52_weeks="7.80"
last_trade_date="3/3/2017"
last_trade_price="4.82"
last_trade_size="104023"
last_trade_time="4:00pm"
low="4.80"
low_52_weeks="3.99"
market_capitalization="510.73M"
moving_average_200_day="5.25"
moving_average_50_day="5.22"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="4.82"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-8.17%"
percent_change_from_50_day_moving_average="-7.69%"
percent_change_from_52_week_high="-38.21%"
percent_change_from_52_week_low="+20.80%"
previous_close="4.79"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="23.03"
price_per_sales="17.98"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="12.76"
stock_exchange="NCM"
symbol="KERX"
volume="1310964"
weeks_range_52="3.99 - 7.80"
